FDA approves Perjeta for people with HER2-positive metastatic breast cancer

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved PerjetaTM (pertuzumab).

Seasonal prevention of malaria in African children: analysis of life-saving potential

Giving young children medicine once a month during the rainy season to protect them against malaria could prevent tens of thousands of deaths each year in some areas of Africa, according to new research.

Structure of a retrovirus at a potentially vulnerable stage

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have for the first time uncovered the detailed structure of the shell that surrounds the genetic material of retroviruses, such as HIV, at a crucial and...

Chemotherapy combined with radiotherapy increases survival in brain tumor patients

Patients with a deadly type of brain cancer could benefit from treatment in which chemotherapy is added to radiotherapy.

Human heart development slower than other mammals

The walls of the human heart are a disorganised jumble of tissue until relatively late in pregnancy, despite having the shape of a fully...




To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited